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Ephrins and Eph receptors have key roles in regulation of cell migration during development. We
found that the RacGAP b2-chimaerin (chimerin) bound to EphA2 and EphA4 and inactivated Rac1
in response to ephrinA1 stimulation. EphA4 bound to b2-chimaerin through its kinase domain
and promoted binding of Rac1 to b2-chimaerin. In addition, knockdown of endogenous b2-chima-
erin blocked ephrinA1-induced suppression of cell migration. These results suggest that b2-chima-
erin is activated by EphA receptors and mediates the EphA receptor-dependent regulation of cell
migration.
Structured summary:
MINT-7013428: EphA1 (uniprotkb:Q60750) physically interacts (MI:0218) with Chimaerin beta 2 (uni-
protkb:Q80XD1-2) and EphA4 (uniprotkb:O08542) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013515: Chimaerin beta 2 (uniprotkb:Q80XD1-2) physically interacts (MI:0218) with Rac1 (uni-
protkb:P63001) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013410: EphA1 (uniprotkb:Q60750) physically interacts (MI:0218) with Chimaerin beta 1 (uni-
protkb:Q80XD1-1) and EphA4 (uniprotkb:O08542) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013503: Chimaerin beta 1 (uniprotkb:Q80XD1-1) physically interacts (MI:0218) with EphA4 (uni-
protkb:O08542) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013472: Chimaerin beta 2 (uniprotkb:Q80XD1-2) physically interacts (MI:0218) with EphA2 (uni-
protkb:O43921) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013450: EphA1 (uniprotkb:Q60750) physically interacts (MI:0218) with EphA2 (uni-
protkb:O43921) and Chimaerin beta 2 (uniprotkb:P52757-1) by anti tag coimmunoprecipitation (MI:0007)
MINT-7013491: Chimaerin beta 2 (uniprotkb:Q80XD1-2) physically interacts (MI:0218) with EphA4 (uni-
protkb:O08542) by anti tag coimmunoprecipitation (MI:0007)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction anisms that regulate Rac activity during cell migration are not fullyThe regulation of cell migration is essential for the formation
and maintenance of tissue organization during development. It is
already well known that members of the Rho family of small GTP-
ases are key regulators of the actin cytoskeleton in diverse cellular
functions including cell migration [1]. Among Rho family GTPases,
Rac is activated at the leading edge of motile cells and induces the
formation of actin-rich lamellipodia protrusions, which serves as a
major driving force of cell movement [2]. However, precise mech-chemical Societies. Published by E
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Katoh).understood.
Ephrins are cell-surface-bound ligands for Eph receptors, which
comprise the largest family of receptor tyrosine kinases. There are
two classes of Eph receptors, EphA and EphB, based on homology
and binding afﬁnity for two distinct types of membrane-anchored
ephrin ligands. EphA and EphB receptors preferentially bind to
class A and class B ephrins, respectively, although interclass bind-
ing occurs among certain family members [3]. Eph receptors have
many important functions during development, and one major role
of Eph receptor signaling is to mediate cell contact-dependent
repulsion, which contributes to the restriction of cell movement
required to form patterns of cell organization [4].
Chimaerins are members of RhoGAP proteins that show speciﬁc
GTPase-activating protein (GAP) activity toward Rac. The chimaer-
in (chimerin) family is composed of four members in mam-
mals: a1-, a2-, b1-, and b2-chimaerin, and these isoforms arelsevier B.V. All rights reserved.
1238 S. Takeuchi et al. / FEBS Letters 583 (2009) 1237–1242alternatively spliced products from the a- and b-chimaerin genes
[5]. All chimaerins have the RacGAP catalytic domain together with
a single C1 domain that binds to the lipid second messenger diac-
ylglycerol (DAG), and previous studies have shown that the C1
domain is important for the subcellular localization of chimaerins
[6,7]. a2- and b2-chimaerin also have an additional N-terminal Src-
homology 2 (SH2) domain. b2-Chimaerin is expressed in various
cell types, and recent studies have shown that b2-chimaerin is in-
volved in the downstream signaling pathway of epidermal growth
factor and T-cell receptors [7,8].
We and others recently demonstrated that a2-chimaerin bound
to EphA4 and mediated EphA4-dependent corticospinal axon guid-
ance [9–12]. In this study, we revealed that b2-chimaerin also
bound to EphA receptors and mediated the EphA receptor-depen-
dent regulation of cell movement.2. Materials and methods
2.1. Plasmids and antibodies
The coding sequences for b2-chimaerin and EphA2 were ob-
tained by reverse transcriptase-PCR (RT-PCR) from mouse brain
and HeLa cells, respectively. Plasmids expressing Myc-EphA4 and
EphA4-FF (Y596F/Y602F) were generated as described previously
[9]. Deletion mutants of EphA4, EphA4-DS, lacking the Sterile a-
motif (SAM) domain (amino acids 1-881), and EphA4-DKS, lacking
both the kinase and SAM domains (amino acids 1-614) were gen-
erated by a PCR-based method. pCAG encoding enhanced yellow
ﬂuorescent protein (EYFP) was a generous gift from Drs. J. Miyazaki
(Osaka University) and T. Saito (Chiba University). The short hair-
pin RNAs (shRNAs) for human b-chimaerin (b-chimaerin shRNA-
893 and shRNA-1191) were designed to target 19 nucleotides of
the human b2-chimaerin transcript (shRNA-893, nucleotides 893-
911, 50-CTATGAACACATTGGATAT-30; shRNA-1191, nucleotides
1191-1209, 50-GTACACAAACAGTGTTCCA-30) and were expressed
using an shRNA expression vector, pSilencer (Ambion). The control
shRNA was designed as described previously [7].
The antibodies were purchased commercially: anti-Myc mono-
clonal 9E10, anti-HA polyclonal Y-11, and anti-EphA2 polyclonal
C20 antibodies (Santa Cruz Biotechnology); anti-HA monoclonal
3F10 (Roche); anti-Rac1 monoclonal antibody (BD Biosciences);
anti-b2-chimaerin polyclonal antibody (Abcam); anti-phosphoty-
rosine monoclonal 4G10 and anti-EphA4 polyclonal antibodies
(Upstate); horseradish peroxidase-conjugated secondary antibod-
ies (DAKO). Immunoprecipitation and immunoblotting were
performed as described previously [9].
2.2. Cell culture and transfection
HEK293T, COS-7, and HeLa cells were grown in Dulbecco’s mod-
iﬁed Eagle’s medium containing 10% fetal bovine serum, 4 mM glu-
tamine, 100 units/ml of penicillin, and 0.1 mg/ml of streptomycin in
humidiﬁed air containing 5% CO2 at 37 C. Cells were transfected
with the indicated expression vectors using Lipofectamine Plus
(Invitrogen) for HEK293T cells, or Lipofectamine 2000 (Invitrogen)
for COS-7 and HeLa cells, according to the manufacturer’s
instructions.
2.3. Measurement of Rac1 activity
Rac1 activity in COS-7 cells was measured as described previ-
ously [9]. Densitometry analysis was performed with ImageJ soft-
ware, and relative Rac1 activity was determined by the amount
of Rac1 bound to GST-CRIB normalized to the amount of Rac1 in
cell lysates.2.4. Migration assay
Migration of HeLa cells was evaluated by Transwell migration
assays as described previously [13]. Cells were co-transfected with
the indicated shRNA and EYFP expression vectors to visualize the
transfected cells. The cells were plated at a density of 1  104 cells
onto the upper chamber of a Transwell ﬁlter (Costar; 8 lm pore
size). For each experiment, the number of cells in ﬁve random
ﬁelds on the underside of the ﬁlter was counted, and four indepen-
dent ﬁlters were analyzed. The expression level of endogenous
b2-chimaerin was examined by semi-quantitative RT-PCR as de-
scribed previously [13]. The PCR was performed using the primers:
b2-chimaerin forward, 50-ATTCTCGAGATGGCAGCATCCAGCAACTC-
30, and b2-chimaerin reverse, 50-AATGCGGCCGCTTAGAATAAAA
CGTCTTCGTTTTC-30; glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward, 50-GCTGCTTTTAACTCTGGTAAAG-30, and GAPDH
reverse, 50-GTAGCCAAATTCGTTGTCATAC-30.3. Results
a2-Chimaeirin associates with EphA4 through its carboxyl ter-
minal region containing the RacGAP catalytic domain [9]. Because
the RacGAP domains of a- and b-chimaerins share 77% identity
[5], we examined the interaction between b-chimaerin and EphA4.
When HA-tagged b-chimaerin was co-expressed with Myc-tagged
EphA4 in HEK293T cells, both b1-chimaerin and b2-chimaerin
were co-immunoprecipitated with EphA4 from the cell lysates
with Fc region-fused ephrinA1 (Fig. 1A). The interactions between
b-chimaerins and EphA4 were also demonstrated by immunopre-
cipitation with anti-HA antibody (Fig. 1B). In addition, b2-chimaer-
in bound to another EphA receptor EphA2 (Fig. 1B). We also
observed the interaction of endogenous b2-chimaerin with EphA2
in HEK293T cells (Fig. 1C). The cytoplasmic region of Eph receptors
contains a protein tyrosine kinase domain and a SAM domain
(Fig. 1D). To identify the region of EphA4 receptor responsible for
binding to b2-chimaerin, we constructed deletion mutants of
EphA4, EphA4-DS, lacking the SAM domain (amino acids 1-881),
and EphA4-DKS, lacking both the kinase and SAM domains (amino
acids 1-614). By immunoprecipitation experiments with Fc region-
fused ephrinA1, b2-chimaerin was co-immunoprecipitated with
EphA4-DS as well as with wild-type EphA4 (EphA4-WT), but not
with EphA4-DKS (Fig. 1E), indicating that the kinase domain of
EphA4 is important for the interaction with b2-chimaerin. We also
found that b2-chimaerin was co-immunoprecipitated with EphA4-
FF, containing mutations in the two conserved tyrosine residues in
the juxtamembrane region essential for the kinase activity of
EphA4 [14] (Fig. 1D and E), suggesting that the interaction between
b2-chimaerin and EphA4 does not require the kinase activity of
EphA4.
To determine whether b2-chimaerin regulates Rac activity in
response to EphA4 activation, we transfected COS-7 cells with
EphA4 (EphA4-WT or EphA4-FF) and b2-chimaerin, and measured
the Rac1 activity in the presence or absence of ephrinA1 stimula-
tion. We found that ephrinA1 stimulation inactivated Rac1 in cells
expressing EphA4-WT and b2-chimaerin, but not in cells express-
ing EphA4-FF and b2-chimaerin (Fig. 2A). We conﬁrmed that
over-expression of b2-chimaerin had no effect on the kinase activ-
ity of EphA4 by detecting auto-phosphorylation of the receptor
(Fig. 2B). These results suggest that b2-chimaerin inactivates
Rac1 in response to EphA4 activation.
The crystal structure of b2-chimaerin has been reported, and
the result shows that, in the inactive state of b2-chimaerin, the
Rac binding is blocked by protrusion of N terminus into the active
site of RacGAP domain [15]. Indeed, the interaction between b2-
chimaerin and Rac1 was barely detectable by immunoprecipitation
Fig. 1. b2-Chimaerin binds to EphA receptors. (A) Cell lysates from HEK293T cells transfected with the indicated plasmids were immunoprecipitated with Fc region-fused
ephrinA1, and bound proteins and total cell lysates were analyzed by immunoblotting. (B) Cell lysates from HEK293T cells were immunoprecipitated with anti-HA antibody,
and bound proteins and total cell lysates were analyzed by immunoblotting. (C) Cell lysates from HEK293T cells were immunoprecipitated with Fc region-fused ephrinA1,
and bound proteins and total cell lysates were analyzed by immunoblotting with anti-b2-chimaerin and EphA2 antibodies. (D) The EphA4 constructs used in this study. TM,
transmembrane domain; KD, kinase domain; SAM, Sterile a-motif domain. (E) Cell lysates from HEK293T cells transfected with the indicated plasmids were
immunoprecipitated with Fc region-fused ephrinA1, and bound proteins and total cell lysates were analyzed by immunoblotting.
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Myc-tagged constitutively active Rac1. However, the amount of
Rac1 binding to b2-chimaerin was dramatically increased when
b2-chimaerin was co-expressed with EphA4 (Fig. 3). On the other
hand, co-expression with the kinase inactive mutant of EphA4,
EphA4-FF, also promoted the Rac1 binding to b2-chimaerin, but
the amount of bound Rac1 was greatly reduced. These results sug-
gest that exposing the RacGAP domain in b2-chimaerin to form the
active conformation requires both EphA4 binding and its kinase
activity. In this experiment, we found that b2-chimaerin was tyro-
sine-phosphorylated in cells expressing EphA4-WT but was not in
cells expressing EphA4-FF (Fig. 3).
Finally, to investigate whether b2-chimaerin is involved in the
cellular response of EphA receptor activation, we used a Transwellmigration assay. We generated two shRNA expression vectors
against b-chimaerin (shRNA-1191, targeting the b1- and b2-chima-
erin common sequence; shRNA-893, targeting the b2-chimaerin-
speciﬁc sequence), both of which effectively reduced the amount
of endogenous b2-chimaerin mRNA (Fig. 4A). The transfected cells
were plated in the upper chamber of the ﬁlters and were allowed
to migrate for 4 h toward the lower chamber ﬁlled with medium
containing ephrinA1-Fc or control Fc. In control HeLa cells, ephri-
nA1 inhibited cell migration toward the underside of the ﬁlters.
However, knockdown of b2-chimaerin blocked the inhibitory effect
of ephrinA1 on cell migration (Fig. 4B). We also found that Rac1
activity was signiﬁcantly increased in cells transfected with b2-
chimaerin shRNA compared with that in control shRNA-transfec-
ted cells after stimulation with ephrinA1 (Fig. 4C). These results
Fig. 2. EphrinA1 inactivates Rac1 in cells expressing EphA4 and b2-chimaerin. (A)
COS-7 cells transfected with the indicated plasmids were stimulated with pre-
clustered ephrinA1-Fc (A1) or control Fc (Fc) (2 lg/ml) in serum-free medium for
5 min. GTP-bound Rac1 was identiﬁed by SDS–PAGE and immunoblotting, and its
levels were measured and normalized to the corresponding total Rac1 levels. The
value from cells expressing b2-chimaerin and EphA4-WT treated with control Fc
was arbitrarily set at 1. Results are the means ± S.E.M.s in three independent
experiments (*P < 0.05). (B) Cell lysates from HEK293T cells transfected with the
indicated plasmids were immunoprecipitated with Fc region-fused ephrinA1, and
bound proteins and total cell lysates were analyzed by immunoblotting with
antibodies against Myc, HA, and phosphotyrosine (p-Tyr).
Fig. 3. EphA4 promotes the interaction between b2-chimaerin and Rac1. Cell
lysates from HEK293T cells transfected with the indicated plasmids were immu-
noprecipitated with anti-HA antibody, and bound proteins and total cell lysates
were analyzed by immunoblotting with antibodies against Myc, HA, and phospho-
tyrosine (p-Tyr). Similar results were observed in three independent experiments.
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tion of cell migration by regulating Rac1 activity.
4. Discussion
Migrating cells extend protrusions with broad lamellipodia at
the front, which are driven by actin polymerization and are stabi-
lized by adhering to the extracellular matrix. Members of the Rho
family of small GTPases are key regulators of the actin cytoskeleton
in diverse cellular functions including cell migration. In particular,
activation of Rac is required for lamellipodial extension at the lead-
ing edge. Here, we investigated a role of RacGAP b2-chimaerin in
the repulsive signaling of EphA receptor and regulation of cell
migration. b2-Chimaerin interacted with EphA receptors and sup-
pressed Rac activity in response to ephrinA1 stimulation. In addi-
tion, knockdown of endogenous b2-chimaerin in HeLa cells
blocked the ephrinA1-induced suppression of cell migration. Takentogether, our results suggest that b2-chimaerin plays an important
role in the regulation of Rac1 activity and cell migration down-
stream of EphA receptors.
b2-Chimaerin has a single C1 domain in the central region fol-
lowed by a C-terminal RacGAP domain. A study of the crystal
structure of b2-chimaerin has shown that in the inactive state,
the N-terminal region of b2-chimaerin protrudes the C-terminal
RacGAP domain and blocks Rac binding [15]. Previous studies
have established that binding of DAG to the C1 domain is impor-
tant for b2-chimaerin activation and translocation to the plasma
membrane in response to tyrosine kinase receptor or G protein-
coupled receptor activation [5]. Indeed, EphA4 recruits and acti-
vates phospholipase Cc, an enzyme that generates DAG [16].
However, a recent study of a2-chimaerin has revealed that
DAG binding to the C1 domain is insufﬁcient to trigger the trans-
location to the plasma membrane and activation of a2-chimaerin
in cells, and that additional inputs would be required for the
fully active conformation of a2-chimaerin [17]. Our results sug-
gest that both binding of EphA4 with b2-chimaerin and its kinase
activity are important for the EphA4 receptor-induced fully ac-
tive open conformation of b2-chimaerin to allow Rac1 to access
the GAP domain. Because EphA4 activation led to tyrosine phos-
phorylation of b2-chimaerin, it may be one of important steps for
the activation of b2-chimaerin.
In cortical neurons, a2-chimaerin mediates the EphA4 recep-
tor-dependent repulsive axon guidance [9–12]. In this study,
we found that b2-chimaerin bound to EphA receptors and med-
iated EphA receptor-dependent Rac inactivation and suppression
of cell migration. Thus, we conclude that both a- and b-chimae-
rins are key downstream effectors of EphA receptors in their
repulsive responses. Since expressions of a- and b-chimaerins
are differentially regulated in different cell types during develop-
ment [18], they may mediate EphA receptor repulsive signaling
in different cells at different developmental stages, although
Fig. 4. Knockdown of b2-chimaerin blocks the ephrinA1-induced suppression of cell migration. (A) The expression level of endogenous b2-chimaerin mRNA in HeLa cells
transfected with the b2-chimaerin shRNA or the control shRNA was shown by semi-quantitative RT-PCR. GAPDH mRNA was analyzed for endogenous internal control. (B)
Motility of HeLa cells transiently transfected with the shRNA vectors was evaluated by Transwell migration assays. Cells were plated in the upper chamber of the ﬁlters and
were allowed to migrate for 4 h toward the lower chamber ﬁlled with medium containing pre-clustered ephrinA1-Fc or control Fc (5 lg/ml). Relative cell migration was
determined by the number of the transfected cells that had migrated to the underside of the ﬁlter normalized to the total number of the transfected cells, and the value from
control cells treated with control Fc was arbitrarily set at 1. Results are the means ± S.E.M.s in four independent experiments (*P < 0.005). (C) HeLa cells transfected with the
indicated plasmids were stimulated with pre-clustered ephrinA1-Fc (2 lg/ml) in serum-free medium for 5 min. GTP-bound Rac1 was identiﬁed by SDS–PAGE and
immunoblotting, and its levels were measured and normalized to the corresponding total Rac1 levels. The value from cells transfected with control shRNA was arbitrarily set
at 1. Results are the means ± S.E.M.s in four independent experiments (**P < 0.01).
S. Takeuchi et al. / FEBS Letters 583 (2009) 1237–1242 1241further studies are needed to fully understand the roles of a- and
b-chimaerins in EphA receptor signaling.
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